nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.0128	0.0128	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.0128	0.0128	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Ceftaroline fosamil—Infestation—Methylprednisolone—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Prednisolone—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Prednisone—ankylosing spondylitis	0.0111	0.0111	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Triamcinolone—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Ceftaroline fosamil—Erythema—Prednisolone—ankylosing spondylitis	0.0101	0.0101	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00989	0.00989	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Betamethasone—ankylosing spondylitis	0.00989	0.00989	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Prednisone—ankylosing spondylitis	0.00988	0.00988	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00969	0.00969	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00965	0.00965	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00953	0.00953	CcSEcCtD
Ceftaroline fosamil—Erythema—Triamcinolone—ankylosing spondylitis	0.00932	0.00932	CcSEcCtD
Ceftaroline fosamil—Erythema—Methylprednisolone—ankylosing spondylitis	0.0093	0.0093	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.0093	0.0093	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00881	0.00881	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Betamethasone—ankylosing spondylitis	0.00881	0.00881	CcSEcCtD
Ceftaroline fosamil—Convulsion—Prednisolone—ankylosing spondylitis	0.00878	0.00878	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00875	0.00875	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Prednisone—ankylosing spondylitis	0.00861	0.00861	CcSEcCtD
Ceftaroline fosamil—Erythema—Betamethasone—ankylosing spondylitis	0.00846	0.00846	CcSEcCtD
Ceftaroline fosamil—Erythema—Dexamethasone—ankylosing spondylitis	0.00846	0.00846	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00827	0.00827	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Methotrexate—ankylosing spondylitis	0.00826	0.00826	CcSEcCtD
Ceftaroline fosamil—Convulsion—Triamcinolone—ankylosing spondylitis	0.00808	0.00808	CcSEcCtD
Ceftaroline fosamil—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00806	0.00806	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00788	0.00788	CcSEcCtD
Ceftaroline fosamil—Infestation—Methotrexate—ankylosing spondylitis	0.00788	0.00788	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00786	0.00786	CcSEcCtD
Ceftaroline fosamil—Renal failure—Methotrexate—ankylosing spondylitis	0.00774	0.00774	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Prednisone—ankylosing spondylitis	0.00768	0.00768	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Prednisone—ankylosing spondylitis	0.00764	0.00764	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00761	0.00761	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00759	0.00759	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00745	0.00745	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00744	0.00744	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00737	0.00737	CcSEcCtD
Ceftaroline fosamil—Erythema—Prednisone—ankylosing spondylitis	0.00736	0.00736	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Prednisone—ankylosing spondylitis	0.00736	0.00736	CcSEcCtD
Ceftaroline fosamil—Convulsion—Dexamethasone—ankylosing spondylitis	0.00733	0.00733	CcSEcCtD
Ceftaroline fosamil—Convulsion—Betamethasone—ankylosing spondylitis	0.00733	0.00733	CcSEcCtD
Ceftaroline fosamil—Pain—Prednisolone—ankylosing spondylitis	0.00707	0.00707	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Methotrexate—ankylosing spondylitis	0.00707	0.00707	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00698	0.00698	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00693	0.00693	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.0069	0.0069	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.0069	0.0069	CcSEcCtD
Ceftaroline fosamil—Anaemia—Prednisone—ankylosing spondylitis	0.00681	0.00681	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00677	0.00677	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00677	0.00677	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00676	0.00676	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00676	0.00676	CcSEcCtD
Ceftaroline fosamil—Urticaria—Prednisolone—ankylosing spondylitis	0.00657	0.00657	CcSEcCtD
Ceftaroline fosamil—Pain—Triamcinolone—ankylosing spondylitis	0.0065	0.0065	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Methotrexate—ankylosing spondylitis	0.00641	0.00641	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00639	0.00639	CcSEcCtD
Ceftaroline fosamil—Convulsion—Prednisone—ankylosing spondylitis	0.00638	0.00638	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00623	0.00623	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00621	0.00621	CcSEcCtD
Ceftaroline fosamil—Erythema—Methotrexate—ankylosing spondylitis	0.00616	0.00616	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Methotrexate—ankylosing spondylitis	0.00616	0.00616	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00609	0.00609	CcSEcCtD
Ceftaroline fosamil—Urticaria—Triamcinolone—ankylosing spondylitis	0.00604	0.00604	CcSEcCtD
Ceftaroline fosamil—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00603	0.00603	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00601	0.00601	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00601	0.00601	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.006	0.006	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00596	0.00596	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00596	0.00596	CcSEcCtD
Ceftaroline fosamil—Pain—Dexamethasone—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Ceftaroline fosamil—Pain—Betamethasone—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Prednisone—ankylosing spondylitis	0.00584	0.00584	CcSEcCtD
Ceftaroline fosamil—Anaemia—Methotrexate—ankylosing spondylitis	0.00569	0.00569	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Ceftaroline fosamil—Urticaria—Dexamethasone—ankylosing spondylitis	0.00548	0.00548	CcSEcCtD
Ceftaroline fosamil—Urticaria—Betamethasone—ankylosing spondylitis	0.00548	0.00548	CcSEcCtD
Ceftaroline fosamil—Dizziness—Prednisolone—ankylosing spondylitis	0.00547	0.00547	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00546	0.00546	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00546	0.00546	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00546	0.00546	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00546	0.00546	CcSEcCtD
Ceftaroline fosamil—Pruritus—Triamcinolone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Ceftaroline fosamil—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00537	0.00537	CcSEcCtD
Ceftaroline fosamil—Convulsion—Methotrexate—ankylosing spondylitis	0.00533	0.00533	CcSEcCtD
Ceftaroline fosamil—Rash—Prednisolone—ankylosing spondylitis	0.00522	0.00522	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Prednisolone—ankylosing spondylitis	0.00521	0.00521	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.0052	0.0052	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Ceftaroline fosamil—Headache—Prednisolone—ankylosing spondylitis	0.00518	0.00518	CcSEcCtD
Ceftaroline fosamil—Constipation—Prednisone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Ceftaroline fosamil—Dizziness—Triamcinolone—ankylosing spondylitis	0.00503	0.00503	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00502	0.00502	CcSEcCtD
Ceftaroline fosamil—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00502	0.00502	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Ceftaroline fosamil—Nausea—Prednisolone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Ceftaroline fosamil—Pruritus—Dexamethasone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Ceftaroline fosamil—Pruritus—Betamethasone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Methotrexate—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Ceftaroline fosamil—Vomiting—Triamcinolone—ankylosing spondylitis	0.00484	0.00484	CcSEcCtD
Ceftaroline fosamil—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00483	0.00483	CcSEcCtD
Ceftaroline fosamil—Rash—Triamcinolone—ankylosing spondylitis	0.0048	0.0048	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00479	0.00479	CcSEcCtD
Ceftaroline fosamil—Rash—Methylprednisolone—ankylosing spondylitis	0.00479	0.00479	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Ceftaroline fosamil—Urticaria—Prednisone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Ceftaroline fosamil—Headache—Triamcinolone—ankylosing spondylitis	0.00477	0.00477	CcSEcCtD
Ceftaroline fosamil—Headache—Methylprednisolone—ankylosing spondylitis	0.00475	0.00475	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Prednisone—ankylosing spondylitis	0.00475	0.00475	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Prednisone—ankylosing spondylitis	0.00475	0.00475	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Ceftaroline fosamil—Dizziness—Dexamethasone—ankylosing spondylitis	0.00456	0.00456	CcSEcCtD
Ceftaroline fosamil—Dizziness—Betamethasone—ankylosing spondylitis	0.00456	0.00456	CcSEcCtD
Ceftaroline fosamil—Nausea—Triamcinolone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Ceftaroline fosamil—Nausea—Methylprednisolone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Ceftaroline fosamil—Vomiting—Betamethasone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Ceftaroline fosamil—Vomiting—Dexamethasone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Ceftaroline fosamil—Rash—Betamethasone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Ceftaroline fosamil—Rash—Dexamethasone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Betamethasone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Ceftaroline fosamil—Headache—Dexamethasone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Ceftaroline fosamil—Headache—Betamethasone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Ceftaroline fosamil—Pain—Methotrexate—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Ceftaroline fosamil—Pruritus—Prednisone—ankylosing spondylitis	0.00425	0.00425	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Prednisone—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Ceftaroline fosamil—Nausea—Dexamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Ceftaroline fosamil—Nausea—Betamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Ceftaroline fosamil—Urticaria—Methotrexate—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Ceftaroline fosamil—Dizziness—Prednisone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Ceftaroline fosamil—Vomiting—Prednisone—ankylosing spondylitis	0.00382	0.00382	CcSEcCtD
Ceftaroline fosamil—Rash—Prednisone—ankylosing spondylitis	0.00379	0.00379	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Prednisone—ankylosing spondylitis	0.00379	0.00379	CcSEcCtD
Ceftaroline fosamil—Headache—Prednisone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Ceftaroline fosamil—Nausea—Prednisone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Ceftaroline fosamil—Pruritus—Methotrexate—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Ceftaroline fosamil—Dizziness—Methotrexate—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Ceftaroline fosamil—Vomiting—Methotrexate—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Ceftaroline fosamil—Rash—Methotrexate—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Methotrexate—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Ceftaroline fosamil—Headache—Methotrexate—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Ceftaroline fosamil—Nausea—Methotrexate—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
